Dr. Stephen Scholand, MD

NPI: 1679500268
Total Payments
$539,747
2024 Payments
$63,732
Companies
9
Transactions
829
Medicare Patients
1,324
Medicare Billing
$188,891

Payment Breakdown by Category

Other$403,931 (74.8%)
Travel$82,165 (15.2%)
Consulting$40,132 (7.4%)
Food & Beverage$13,519 (2.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $403,931 169 74.8%
Travel and Lodging $82,165 429 15.2%
Consulting Fee $40,132 20 7.4%
Food and Beverage $13,519 211 2.5%

Top Paying Companies

Company Total Records Latest Year
Grifols USA, LLC $427,410 649 $0 (2024)
SANOFI PASTEUR INC. $73,567 104 $0 (2024)
PFIZER INC. $21,704 45 $0 (2023)
Melinta Therapeutics, Inc. $11,284 13 $0 (2018)
Allergan Inc. $4,917 6 $0 (2017)
Grifols Shared Services North America, Inc. $631.43 9 $0 (2024)
Shionogi Inc $124.98 1 $0 (2022)
Paratek Pharmaceuticals, Inc. $56.13 1 $0 (2020)
The Medicines Company $52.46 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $63,732 83 Grifols USA, LLC ($63,603)
2023 $84,561 147 Grifols USA, LLC ($66,397)
2022 $82,476 113 Grifols USA, LLC ($71,555)
2021 $37,627 50 Grifols USA, LLC ($35,164)
2020 $23,008 29 SANOFI PASTEUR INC. ($12,050)
2019 $77,733 132 Grifols USA, LLC ($58,799)
2018 $113,840 174 Grifols USA, LLC ($82,296)
2017 $56,770 101 Grifols USA, LLC ($38,758)

All Payment Transactions

829 individual payment records from CMS Open Payments — Page 1 of 34

Date Company Product Nature Form Amount Type
11/20/2024 Grifols USA, LLC HyperRAB (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,850.00 General
Category: Immunology
11/20/2024 Grifols USA, LLC HyperRAB (Biological) Travel and Lodging In-kind items and services $727.40 General
Category: Immunology
11/20/2024 Grifols USA, LLC HyperRAB (Biological) Travel and Lodging Cash or cash equivalent $494.06 General
Category: Immunology
11/20/2024 Grifols USA, LLC HyperRAB (Biological) Food and Beverage In-kind items and services $125.00 General
Category: Immunology
11/20/2024 Grifols USA, LLC HyperRAB (Biological) Food and Beverage Cash or cash equivalent $26.82 General
Category: Immunology
11/14/2024 Grifols USA, LLC HyperRAB (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,990.00 General
Category: Immunology
11/14/2024 Grifols USA, LLC HyperRAB (Biological) Travel and Lodging In-kind items and services $152.10 General
Category: Immunology
11/14/2024 Grifols USA, LLC HyperRAB (Biological) Food and Beverage In-kind items and services $116.25 General
Category: Immunology
11/14/2024 Grifols USA, LLC HyperRAB (Biological) Travel and Lodging Cash or cash equivalent $99.27 General
Category: Immunology
11/14/2024 Grifols USA, LLC HyperRAB (Biological) Travel and Lodging Cash or cash equivalent $19.50 General
Category: Immunology
11/14/2024 Grifols USA, LLC HyperRAB (Biological) Food and Beverage Cash or cash equivalent $18.13 General
Category: Immunology
11/14/2024 Grifols USA, LLC HyperRAB (Biological) Travel and Lodging Cash or cash equivalent $5.00 General
Category: Immunology
11/13/2024 Grifols USA, LLC HyperRAB (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,990.00 General
Category: Immunology
11/13/2024 Grifols USA, LLC HyperRAB (Biological) Travel and Lodging In-kind items and services $1,254.27 General
Category: Immunology
11/13/2024 Grifols USA, LLC HyperRAB (Biological) Travel and Lodging In-kind items and services $125.10 General
Category: Immunology
11/13/2024 Grifols USA, LLC HyperRAB (Biological) Food and Beverage In-kind items and services $124.99 General
Category: Immunology
11/13/2024 Grifols USA, LLC HyperRAB (Biological) Travel and Lodging Cash or cash equivalent $23.50 General
Category: Immunology
11/13/2024 Grifols USA, LLC HyperRAB (Biological) Travel and Lodging Cash or cash equivalent $16.61 General
Category: Immunology
11/13/2024 Grifols USA, LLC HyperRAB (Biological) Travel and Lodging Cash or cash equivalent $5.00 General
Category: Immunology
11/12/2024 SANOFI PASTEUR INC. Food and Beverage In-kind items and services $16.67 General
10/10/2024 Grifols USA, LLC HyperRAB (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,990.00 General
Category: Immunology
10/10/2024 Grifols USA, LLC HyperRAB (Biological) Food and Beverage In-kind items and services $117.17 General
Category: Immunology
10/10/2024 Grifols USA, LLC HyperRAB (Biological) Travel and Lodging Cash or cash equivalent $52.71 General
Category: Immunology
10/09/2024 Grifols USA, LLC HyperRAB (Biological) Consulting Fee Cash or cash equivalent $1,230.00 General
Category: Immunology
09/05/2024 Grifols USA, LLC HyperRAB (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,495.00 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 297 395 $111,540 $35,079
2022 5 382 668 $179,679 $54,841
2021 6 344 562 $173,648 $51,821
2020 7 301 351 $150,301 $47,150
Total Patients
1,324
Total Services
1,976
Medicare Billing
$188,891
Procedure Codes
23

All Medicare Procedures & Services

23 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 87 87 $40,992 $11,120 27.1%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 87 167 $29,255 $10,467 35.8%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 53 71 $18,371 $6,523 35.5%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 55 55 $19,187 $5,615 29.3%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 15 15 $3,735 $1,354 36.3%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 106 224 $60,092 $18,366 30.6%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 120 281 $52,725 $16,122 30.6%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 80 83 $42,552 $12,740 29.9%
99239 Hospital discharge day management, more than 30 minutes Facility 2022 50 53 $14,965 $4,675 31.2%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 26 27 $9,345 $2,939 31.5%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 86 195 $54,132 $16,312 30.1%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 85 90 $49,803 $14,577 29.3%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 91 194 $39,210 $11,749 30.0%
99239 Hospital discharge day management, more than 30 minutes Facility 2021 45 46 $13,934 $4,188 30.1%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 25 25 $9,009 $2,737 30.4%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2021 12 12 $7,560 $2,257 29.9%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 149 152 $82,288 $25,373 30.8%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2020 38 40 $24,000 $7,697 32.1%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 33 52 $14,274 $4,594 32.2%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 34 60 $11,541 $3,722 32.2%
99220 Hospital observation care, typically 70 minutes Facility 2020 17 17 $8,439 $2,767 32.8%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 14 14 $5,135 $1,551 30.2%
99239 Hospital discharge day management, more than 30 minutes Facility 2020 16 16 $4,624 $1,447 31.3%

About Dr. Stephen Scholand, MD

Dr. Stephen Scholand, MD is a Internal Medicine healthcare provider based in Meriden, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679500268.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Scholand, MD has received a total of $539,747 in payments from pharmaceutical and medical device companies, with $63,732 received in 2024. These payments were reported across 829 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($403,931).

As a Medicare-enrolled provider, Scholand has provided services to 1,324 Medicare beneficiaries, totaling 1,976 services with total Medicare billing of $188,891. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Infectious Disease, Hospitalist
  • Location Meriden, CT
  • Active Since 06/27/2006
  • Last Updated 07/16/2025
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1679500268

Products in Payments

  • HyperRAB (Biological) $237,091
  • HyperRAB SD (Biological) $187,531
  • FLUBLOK QUADRIVALENT (Drug) $17,416
  • TRUMENBA (Biological) $14,316
  • FLUZONE HIGH-DOSE (Drug) $12,773
  • FLUZONE HIGH-DOSE (Biological) $12,418
  • Baxdela (Drug) $11,162
  • FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological) $6,266
  • FLUZONE QUADRIVALENT (Biological) $4,818
  • PREVNAR - 13 (Biological) $4,780
  • MENQUADFI (Biological) $3,059
  • Prolastin-C (Biological) $2,909
  • DALVANCE (Drug) $2,781
  • NO PRODUCT DISCUSSED (Drug) $2,642
  • PREVNAR 20 (Biological) $2,590
  • TEFLARO (Drug) $2,135
  • Td Vaccine (Biological) $450.00
  • Fetroja (Drug) $124.98
  • Vabomere (Drug) $121.83
  • FLUZONE QUADRIVALENT (Drug) $96.96

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Meriden